These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16355016)
1. The cardiometabolic syndrome as a cardiovascular risk factor. Govindarajan G; Whaley-Connell A; Mugo M; Stump C; Sowers JR Am J Med Sci; 2005 Dec; 330(6):311-8. PubMed ID: 16355016 [TBL] [Abstract][Full Text] [Related]
2. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Whaley-Connell A; Johnson MS; Sowers JR Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958 [TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection. Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393 [TBL] [Abstract][Full Text] [Related]
8. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Lastra G; Manrique C; Sowers JR Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222 [TBL] [Abstract][Full Text] [Related]
9. Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review. Nakashima A; Kato K; Ohkido I; Yokoo T Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959901 [TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and the metabolic syndrome. Lann D; Gallagher E; Leroith D Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723 [TBL] [Abstract][Full Text] [Related]
11. Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease. Mao X; Ait-Aissa K; Lagrange J; Youcef G; Louis H Biomed Mater Eng; 2012; 22(1-3):35-48. PubMed ID: 22766701 [TBL] [Abstract][Full Text] [Related]
13. Insulin Resistance and β-Cell Dysfunction in Relation to Cardiometabolic Risk Patterns. Wang T; Zhao Z; Xu Y; Qi L; Xu M; Lu J; Li M; Chen Y; Dai M; Zhao W; Ning G; Wang W; Bi Y J Clin Endocrinol Metab; 2018 Jun; 103(6):2207-2215. PubMed ID: 29590437 [TBL] [Abstract][Full Text] [Related]
15. Introduction: organ involvement in the cardiometabolic syndrome. Hayden MR; Stump CS; Sowers JR J Cardiometab Syndr; 2006; 1(1):16-24. PubMed ID: 17675904 [TBL] [Abstract][Full Text] [Related]
16. Obesity and insulin resistance in resistant hypertension: implications for the kidney. Rao A; Pandya V; Whaley-Connell A Adv Chronic Kidney Dis; 2015 May; 22(3):211-7. PubMed ID: 25908470 [TBL] [Abstract][Full Text] [Related]
17. [NF-kB activation as a molecular basis of pathological process by metabolic syndrome]. Kaĭdashev IP Fiziol Zh (1994); 2012; 58(1):93-101. PubMed ID: 22590744 [TBL] [Abstract][Full Text] [Related]
18. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function]. Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103 [TBL] [Abstract][Full Text] [Related]
19. Hypertension and the metabolic syndrome. Morse SA; Zhang R; Thakur V; Reisin E Am J Med Sci; 2005 Dec; 330(6):303-10. PubMed ID: 16355015 [TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Domingueti CP; Dusse LM; Carvalho Md; de Sousa LP; Gomes KB; Fernandes AP J Diabetes Complications; 2016; 30(4):738-45. PubMed ID: 26781070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]